Altered renal folate handling in hypertensive patients with nephroangiosclerotic damage.
Pizzolo
F
F
Girelli
D
D
Friso
S
S
Pavan
C
C
Martinelli
N
N
Guarini
P
P
Faccini
G
G
Corrocher
R
R
Olivieri
O
O
D016022:Case-Control Studies; D003404:Creatinine / Q000652:urine; D005492:Folic Acid / Q000097:blood / Q000378:metabolism* / Q000652:urine; D005838:Genotype; D005919:Glomerular Filtration Rate; D006710:Homocysteine / Q000097:blood; D006801:Humans; D020138:Hyperhomocysteinemia / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D006977:Hypertension, Renal / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D007511:Ischemia / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics; D009399:Nephrons / Q000098:blood supply / Q000378:metabolism* / Q000503:physiopathology; D012078:Renal Artery Obstruction / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D014805:Vitamin B 12 / Q000235:genetics
D006710:Homocysteine; D005492:Folic Acid; D003404:Creatinine; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D014805:Vitamin B 12